Her 2 in 1.
In this issue of Cancer Cell, Park et al. demonstrate that anti-erbB2 antibody primes adaptive immunity for increased tumor clearance and suggest that chemotherapy may in fact interfere with this process.
Smyth
Mark J
MJ
Peter MacCallum Cancer Centre, St. Andrews Place, East Melbourne, Victoria, Australia. mark.smyth@petermac.org
Stagg
John
J